Clinical Trials

25 trials
RecentStart dateEnrollment
Myocardial Infarction × Clear all
NCT03840928 2023-12-13

PatientSpot Formerly Known as ArthritisPower

Global Healthy Living Foundation

Unknown
40,000 enrolled
CNSDermatologicOtherThoracic

Intervertebral disc disease, Undifferentiated Connective Tissue Diseases, Axial Spondyloarthritis, Alopecia, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Angina, Unstable, Arrhythmias, Cardiac, Arthritis, Juvenile, Arthritis, Rheumatoid, Asthma, Ataxia, Brain Neoplasms, Intracranial Aneurysm, Cluster Headache, Crohn Disease, Cystic Fibrosis, Dermatomyositis, Diabetes Mellitus, Hyperostosis, Diffuse Idiopathic Skeletal, Eczema, Epilepsy, Fibromyalgia, Gout, Craniocerebral Trauma, Headache, Heart Defects, Congenital, Heart Failure, Heart Valve Diseases, Hydrocephalus, Hypertension, Lung Neoplasms, Meningitis, Multiple Sclerosis, Muscular Dystrophies, Myocardial Infarction, Myositis, Obesity, Osteoarthritis, Osteoporosis, Parkinson Disease, Polychondritis, Relapsing, Polymyalgia Rheumatica, Psoriasis, Sleep Apnea Syndromes, Spinal Cord Injuries, Spondylitis, Ankylosing, Giant Cell Arteritis, Granulomatosis with Polyangiitis, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Polymyositis, Tension-Type Headache, Guillain-Barre Syndrome, Bell Palsy, Stroke, Neurocutaneous Syndromes, Pulmonary Disease, Chronic Obstructive, Scleroderma, Diffuse, Peripheral Arterial Disease

NCT02921802 2022-06-14

A Study of Special Use Results Surveillance of Revlimid 5mg Capsules

Celgene

Completed
4,626 enrolled
Classical hematologyMyeloidOtherPlasma cell

Arrhythmias, Cardiac, Constipation, Diarrhea, Heart Failure, Hemorrhage, Hypersensitivity, Infections, Multiple Myeloma, Myelodysplastic Syndromes, Myocardial Infarction, Neutropenia, Peripheral Nervous System Diseases, Thrombocytopenia, Tumor Lysis Syndrome, Lung Diseases, Interstitial, Renal Insufficiency, Venous Thromboembolism, Teratogenesis

NCT02922543 2022-06-14

A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use

Celgene

Completed
361 enrolled
Classical hematologyOtherPlasma cell

Arrhythmias, Cardiac, Constipation, Diarrhea, Heart Failure, Hemorrhage, Hypersensitivity, Infections, Multiple Myeloma, Myocardial Infarction, Neutropenia, Peripheral Nervous System Diseases, Thrombocytopenia, Tumor Lysis Syndrome, Lung Diseases, Interstitial, Renal Insufficiency, Venous Thromboembolism, Teratogenesis